The use of 'real-time' complement analysis to differentiate atypical haemolytic uraemic syndrome from other forms of thrombotic microangiopathies

British Journal of Haematology

Volumn 158, Issue 3, 2012, Pages 424-425

  Prohászka, Zoltán ^a   Varga, Lilian ^a   Füst, George ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

ADAMTS13; Atypical haemolytic uraemic syndrome; Complement alternative pathway; Differential diagnosis; Thrombotic thrombocytopenic purpura

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; AUTOANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H ANTIBODY; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; BLOODY DIARRHEA; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT SYSTEM; CONTROLLED STUDY; DIAGNOSTIC KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC DISORDER; HEMOLYTIC UREMIC SYNDROME; HUMAN; LABORATORY TEST; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; CREATININE; FEMALE; HUMANS; MALE; PURPURA, THROMBOTIC THROMBOCYTOPENIC; THROMBOTIC MICROANGIOPATHIES;

EID: 84863843521     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09168.x     Document Type: Letter

References (9)

1. Ariceta, G., Besbas, N., Johnson, S., Karpman, D., Landau, D., Licht, C., Loirat, C., Pecoraro, C., Taylor, C.M., Van de Kar, N., Vandewalle, J. & Zimmerhackl, L.B. (2009) Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatric Nephrology, 24, 687-696.
2. Besbas, N., Karpman, D., Landau, D., Loirat, C., Proesmans, W., Remuzzi, G., Rizzoni, G., Taylor, C.M., Van de Kar, N. & Zimmerhackl, L.B. (2006) A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney International, 70, 423-431.
3. Cataland, S.R., Yang, S. & Wu, H.M. (2012) The use of ADAMTS13 activity, platelet count, and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura from other thrombotic microangiopathies. British Journal of Haematology, 157, 501-503.
4. Loirat, C. & Fremeaux-Bacchi, V. (2011) Atypical hemolytic uremic syndrome. Orphanet Journal of Rare Diseases, 6, 60.
5. Noris, M. & Remuzzi, G. (2009) Atypical hemolytic-uremic syndrome. New England Journal of Medicine, 361, 1676-1687.
6. Roumenina, L.T., Loirat, C., Dragon-Durey, M.A., Halbwachs-Mecarelli, L., Sautes-Fridman, C. & Fremeaux-Bacchi, V. (2011) Alternative complement pathway assessment in patients with atypical HUS. Journal of Immunological Methods, 365, 8-26.
7. Scheiring, J., Rosales, A. & Zimmerhackl, L.B. (2010) Clinical practice. Today's understanding of the haemolytic uraemic syndrome. European Journal of Pediatrics, 169, 7-13.
8. Seelen, M.A., Roos, A., Wieslander, J., Mollnes, T.E., Sjoholm, A.G., Wurzner, R., Loos, M., Tedesco, F., Sim, R.B., Garred, P., Alexopoulos, E., Turner ., M.W. & Daha, M.R. (2005) Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. Journal of Immunological Methods, 296, 187-198.
9. Taylor, C.M., Machin, S., Wigmore, S.J. & Goodship, T.H. (2010) Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom. British Journal of Haematology, 148, 37-47.